$TEVA Catches Fresh Momo as Malaria Drugs Get the Nod
TEVA
shares are popping to start off the week as the company gets into the middle of the chloroquine emphasis to battle the COVID-19 outbreak. The longer-term picture is defined by the potential for fresh momentum after successfully holding key support.